God  our Guide  No-1 in alternative medicine, modern guidelines

 

CIDPUSA.ORG

 
Home

Cancer therapy

Cancer cure

Broccoli CANCER

B-17 cancer

Women Killer Disease

Cancer and Bacteria

IVIG
Diet anti-inflammatory
Cancer Prevention
Services Page
Hepatitis
Autoimmune diseases

Cancer Help

Bible healing
Pemphagoid

 

Women Heart attack
Bras & Breast Cancer
Breast Cancer Chemic
Mammogram cancer
Breast Massage
Breast Implants
Breast Exam
Breast Lymph
Breast Feeding
Bra Chemicals
Breast Cancer Herbs
Bible Diet
Breast nutrients
Circadian Rhythm

Cancer & Flaxseed oil

Cancer Book

Vitamins and cancer

Cancer Clinic

Cancer & Lipstick

Green tea and cancer risk

Beet Root  anti cancer

Curry Powder

 

 

 

  

 Issels Cancer treatment
  All diseases are autoimmune permanently treatable please read our e-book .  
Special GoogleHealth Search
 

Vitamins        
 

Laetrile Saga,

Part 2: Cancer Treatment and Prevention

Return to page-1


Another enzyme known as rhodanese is important in this process. Normal healthy cells contain rhodanese which protects them from the activated cyanide. Most cancer cells are deficient in this enzyme, leaving them vulnerable to the poison. Tumor destruction begins once the cyanide is released within the malignancies, meaning laetrile therapy is selectively toxic to cancer cells while remaining non-toxic to normal cells.

Benzaldehyde –- a known painkiller –- is also released during the breakdown of laetrile, and may account for the analgesic benefits reported from its use. Some scientists believe that this substance is also an anticancer agent (1).

Countless case studies, as well as this author's own use for nearly two years, have shown laetrile to be non-toxic and effective in controlling cancer; however, proponents of the substance do not consider it to be a stand-alone treatment. Laetrile is but one component of a comprehensive holistic protocol that includes enzymes, nutritional therapy with little or no animal protein, and cleansing of bodily toxins.

Dosage

Early doses used in research were tentative and cautious, often as low as fifty to one hundred milligrams per dosage. By 1974 however, daily intravenous doses of six to nine grams became the standard treatment. Improvement was generally seen with an accumulation of fifty to seventy grams over a seven to ten day period.

Patients seeking treatments have had to travel to Mexico or Germany since the FDA banned the sale and use of laetrile in 1971, for reasons that will become clear in the second part of this report. This author traveled to the Oasis of Hope Hospital in Tijuana, Mexico for alternative cancer treatments that included nine grams of intravenous laetrile for eighteen straight days. Follow-up home treatment included daily oral doses of two grams and an intramuscular injection of three grams, administered three times per week. Sustaining this protocol required multiple trips to Mexico at six-month intervals since the U.S. will only allow an individual to bring a six-month supply of treatments with a written prescription.

This regimen became increasingly disruptive and ultimately cost-prohibitive; however, it was an important component of my holistic protocol for more than eighteen months, during which time the cancer gradually receded. I continue to derive the benefits of laetrile from raw whole food sources, including an abundance of fruits, seeds, and sprouted grains. It's important to note that cooking does not destroy the amygdaline.

Sources of Laetrile

 Apricot Kernals

In addition to whole foods, laetrile can be obtained through oral supplements found from many online sources. These supplements include dosage recommendations. Apricot kernels are available at most health food stores, although it's difficult to ingest these bitter seeds. To make them palatable they may be ground and added to other foods as a seasoning.

Part two of this report will cover the opposition, oppression and medical deception surrounding the use of laetrile in the treatment of cancer.

Source:   Moss, Ph.D., Ralph W.: The Cancer Industry. State College, PA: Equinox Press, 1999, pg. 132; pp. 140-1